Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria.

Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria.

Dihydroartemisinin-piperaquine (DHP) is an important new treatment for drug-resistant malaria, although pharmacokinetic studies on the combination are limited. In Papua, Indonesia, we assessed determinants of the therapeutic efficacy of DHP for uncomplicated malaria. Plasma piperaquine concentration...

Full description

Bibliographic Details
Main Authors:	Price, R, Hasugian, A, Ratcliff, A, Siswantoro, H, Purba, H, Kenangalem, E, Lindegardh, N, Penttinen, P, Laihad, F, Ebsworth, E, Anstey, N, Tjitra, E
Format:	Journal article
Language:	English
Published:	2007

Similar Items

Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.
by: Hasugian, A, et al.
Published: (2007)

Efficacy of Artemisinin-Naphtoquine and Dihydroartemisinin-Piperaquine for uncomplicated malaria patient at primary health care
by: Hadjar Siswantoro, et al.
Published: (2015-01-01)

Efficacy of Artemisinin-Naphtoquine and Dihydroartemisinin-Piperaquine for uncomplicated malaria patient at primary health care
by: Hadjar Siswantoro, et al.
Published: (2015-01-01)

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy
by: Poespoprodjo, JR, et al.
Published: (2014)

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy.
by: Jeanne Rini Poespoprodjo, et al.
Published: (2014-01-01)

Artemisinin-napthoquine versus dihydroartemisinin-piperaquine in adult subjects with Plasmodium vivax infection
by: Armedy Ronny Hasugian, et al.
Published: (2016-03-01)

Artemisinin-napthoquine versus dihydroartemisinin-piperaquine in adult subjects with Plasmodium vivax infection
by: Armedy Ronny Hasugian, et al.
Published: (2016-03-01)

Treatment policy change to dihydroartemisinin-piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes
by: Poespoprodjo, J, et al.
Published: (2015)

Amodiaquine plus artesunate versus dihydroartemisinin-piperaquine for drug resistant P.falciparum and P.vivax in Papua, Indonesia
by: Armedy, R, et al.
Published: (2006)

Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
by: Ratcliff, A, et al.
Published: (2007)

Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia.
by: Ratcliff, A, et al.
Published: (2007)

Treatment-seeking behavior after the implementation of a unified policy of dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua, Indonesia
by: Devine, A, et al.
Published: (2017)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
by: Rijken, M, et al.
Published: (2011)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
by: Tarning, J, et al.
Published: (2012)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
by: Zongo, I, et al.
Published: (2014)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
by: Tarning, J, et al.
Published: (2012)

Efficacy and safety of dihydroartemisinin-piperaquine.
by: Myint, H, et al.
Published: (2007)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
by: Tarning, J, et al.
Published: (2008)

Efficacy of existing antimalarial drugs for uncomplicated malaria in Timika, Papua, Indonesia
by: Siswantaro, H, et al.
Published: (2006)

Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants.
by: Creek, D, et al.
Published: (2013)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
by: Tarning, J, et al.
Published: (2007)

Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.
by: Phyo, A, et al.
Published: (2011)

Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria.
by: Mytton, O, et al.
Published: (2007)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
by: Issaka Zongo, et al.
Published: (2014-01-01)

Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana
by: Benjamin Abuaku, et al.
Published: (2023-01-01)

Efficacy and safety of artemisinin-naphthoquine <it>versus</it> dihydroartemisinin-piperaquine in adult patients with uncomplicated malaria: a multi-centre study in Indonesia
by: Tjitra Emiliana, et al.
Published: (2012-06-01)

Dihydroartemisinin - piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report
by: Rijken, M, et al.
Published: (2007)

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
by: Smithuis, F, et al.
Published: (2006)

Treatment failure of dihydroartemisinin/piperaquine for plasmodium falciparum malaria, Vietnam
by: Phuc, B, et al.
Published: (2017)

In vivo and in vitro efficacy of chloroquine against Plasmodium malariae and P. ovale in Papua, Indonesia.
by: Siswantoro, H, et al.
Published: (2011)

In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.
by: Hasugian, A, et al.
Published: (2009)

Electrocardiographic effect of artemisinin-piperaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine treatment in falciparum malaria patients
by: Wanting Wu, et al.
Published: (2021-02-01)

Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam
by: Bui Quang Phuc, et al.
Published: (2017-04-01)

Therapeutic response to Dihydroartemisinin-Piperaquine for P. falciparum and P. vivax nine years after its introduction in Southern Papua, Indonesia
by: Poespoprodjo, JR, et al.
Published: (2018)

A randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine combined with primaquine for radical treatment of vivax malaria in Sumatera, Indonesia.
by: Pasaribu, A, et al.
Published: (2013)

Alternative treatment options for chloroquine resistant Plasmodium vivax in Papua, Indonesia
by: Price, R, et al.
Published: (2005)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
by: Chotsiri, P, et al.
Published: (2019)

Therapeutic and Transmission-Blocking  Efficacy of Dihydroartemisinin/Piperaquine and Chloroquine against Plasmodium vivax Malaria, Cambodia
by: Jean Popovici, et al.
Published: (2018-08-01)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
by: Lwin, K, et al.
Published: (2012)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
by: Lwin, K, et al.
Published: (2012)